Home
About Us
- Our Blogs
Depression and TMS
TMS Resources
Reviews
Locations
Blog
Contact Us

Call (310) 246-9110

Home
About Us
- Our Blogs
Depression and TMS
TMS Resources
Reviews
Locations
Blog
Contact Us

Our Blogs

Glendale

Home
About Us
Our Locations
Reviews
Contact Us
Privacy Policy

Premier TMS Centers | Clinically Proven Treatment for Depression Located in Beverly Hills, Long Beach, and Glendale

N/a

Long Beach

Long Beach

333 W. Broadway,
Suite 201
Long Beach, CA 90802

Get Directions

Glendale

Glendale

130 N. Brand Blvd,
Ste 300
Glendale, CA 90210

Get Directions

Beverly Hills

Beverly Hills

416 N. Bedford Dr,
Ste 406
Beverly Hills, CA 90210

Get Directions

Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.

The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).

Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).

NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.

Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).

NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.

**Outcomes Registry data was published by Sackeim HA, et al. J Affective Disorders, 2020, 277(12):65-74. The outcomes reported represent the subset of study patients for which the CGI-S data was reported before and after an acute course of NeuroStar TMS. Patients were treated under real-world conditions where patients may have been prescribed concomitant depression treatments including medications. “Measurable relief” was defined as a CGI-S score <=3 and “complete remission” was defined as a CGI-S score <=2 at the end of treatment.

Copyright © Premier TMS Centers, 2024. All Rights Reserved.

Cleantalk Pixel